In TCR-Stimulated T-cells, N-ras Regulates Specific Genes and Signal Transduction Pathways

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Lynch, Stephen J ^a   Zavadil, Jiri ^b,c   Pellicer, Angel ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^c INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

H RAS PROTEIN; MEMBRANE PROTEIN; MESSENGER RNA; N RAS PROTEIN; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG; LYMPHOCYTE ANTIGEN RECEPTOR; RAS PROTEIN; TRANSCRIPTOME;

ANIMAL CELL; ARTICLE; CD4+ T LYMPHOCYTE; CHST1 GENE; CONTROLLED STUDY; DNTT GENE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; IMMUNOCOMPETENT CELL; LARS2 GENE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN ANALYSIS; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SLC9A6 GENE; T LYMPHOCYTE ACTIVATION; THYMOCYTE; TRANSCRIPTOMICS; ANIMAL; CYTOLOGY; DNA MICROARRAY; GENETIC ASSOCIATION STUDY; GENETIC DATABASE; GENETICS; KNOCKOUT MOUSE; LYMPHOCYTE ACTIVATION; METABOLISM; REPRODUCIBILITY; SPLEEN;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; DATABASES, GENETIC; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION STUDIES; LYMPHOCYTE ACTIVATION; MICE, KNOCKOUT; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RAS PROTEINS; RECEPTORS, ANTIGEN, T-CELL; REPRODUCIBILITY OF RESULTS; SIGNAL TRANSDUCTION; SPLEEN; THYMOCYTES; TRANSCRIPTOME;

EID: 84878635230     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0063193     Document Type: Article

References (43)

1. Leon J, Guerrero I, Pellicer A, (1987) Differential expression of the ras gene family in mice. Mol Cell Biol 7: 1525-1540.
2. Umanoff H, Edelmann W, Pellicer A, Kucherlapati R, (1995) The murine N-ras gene is not essential for growth and development. Proc Natl Acad Sci U S A 92: 1709-1713.
3. Johnson L, Greenbaum D, Cichowski K, Mercer K, Murphy E, et al. (1997) K-ras is an essential gene in the mouse with partial functional overlap with N-ras. Genes Dev 11: 2468-2481.
4. Koera K, Nakamura K, Nakao K, Miyoshi J, Toyoshima K, et al. (1997) K-ras is essential for the development of the mouse embryo. Oncogene 15: 1151-1159.
5. Esteban LM, Vicario-Abejon C, Fernandez-Salguero P, Fernandez-Merarde A, Swaminathan N, et al. (2001) Targeted genomic disruption of H-ras and N-ras, individually or in combination, reveals the dispensability of both loci for mouse growth and development. Mol Cell Biol 21: 1444-1452.
6. Bos JL, (1989) Ras oncogenes in human cancer: a review. Cancer Res 49: 4682-4689.
7. Bollag G, McCormick F, (1991) Differential regulation of rasGRP and neurofibromatosis gene product activities. Nature 351: 576-579.
8. Yan J, Roy S, Apollini A, Lane A, Hancock JF, (1998) Ras isoforms vary in their ability to activate Raf-1 and phosphoinositide 3-kinase. J Biol Chem 273: 24052-24056.
9. Malumbres M, Pellicer A, (1998) Ras pathways to cell cycle control and cell transformation. Front In Biosci 3: 887-912.
10. Dustin ML, Chakraborty AK, Shaw AS (2010) Understanding the structure and function of the immunological synapse. Cold Spring Harb Perspect Biol: a002311 (e-publication).
11. Wolfman JC, Palmby T, Der CJ, Wolfman A, (2002) Cellular N-Ras promotes cell survival by downregulation of Jun N-terminal protein kinase and p38. Mol Cell Biol 22: 1589-1606.
12. Alberola-Ila J, Hernandez-Hoyos G, (2003) The Ras/MAPK cascade and the control of positive selection. Immunol Rev 191: 79-96.
13. Fruman DA, (2004) Phospoinositide 3-kinase and its targets in B-cell and T-cell signaling. Curr Opin Immunol 16: 304-320.
14. Perez de Castro I, Diaz R, Malumbres M, Hernandez MI, Jagirdar J, et al. (2003) Mice deficient for N-ras: impaired antiviral immune response and T-cell function. Cancer Res 63: 1615-1622.
15. Farr CJ, Saiki RK, Erlich HA, McCormick F, Marshall CJ, (1988) Analysis of RAS gene mutations in Acute Myeloid Leukemia by Polymerase Chain Reaction and oligonucleotide probes. Proc Natl Acad Sci - USA 85: 1629-1633.
16. Jannsen JWG, Steenvoorden ACM, Lyons J, Anger B, Bohlke JU, et al. (1987) RAS gene mutations in acute and chronic myelocytic leukemias, chronic myeloproliferative disorders, and myelodysplastic syndromes. Proc Natl Acad Sci - USA 84: 9228-9232.
17. Mangues R, Symmans WF, Lu S, Schwartz S, Pellicer A, (1996) Activated N-ras oncogene and N-ras proto-oncogene act through the same pathway for in vivo tumorigenesis. Oncogene -13: 1053-1063.
18. Sinn E, Muller W, Pattengale P, Tepler I, Wallace R, Leder P, (1987) Coexpression of MMTV/v-Ha-ras and MMTV/c-myc genes in transgenic mice: synergistic action of oncogenes in vivo. Cell 49: 465-475.
19. Apolloni A, Prior IA, Lindsay M, Parton RG, Hancock JF, (2000) H-ras but not K-ras traffics to the plasma membrane through the exocytic pathway. Mol Cell Biol 20: 2475-2487.
20. Choy E, Chiu VK, Silletti J, Feoktistov M, Morimoto T, et al. (1999) Endomembrane trafficking of ras: the CAAX motif targets proteins to the ER and Golgi. Cell 98: 69-80.
21. Chiu VK, Bivona T, Hach A, Sajous JB, Silletti J, et al. (2002) Ras signalling on the endoplasmic reticulum and the Golgi. Nature Cell Biol 4: 343-350.
22. Perez de Castro I, Bivona TG, Philips MR, Pellicer A, (2004) Ras activation in Jurkat cells following low-grade stimulation of the T-cell receptor is specific to N-ras and occurs only on the Golgi apparatus. Mol Cell Biol 24: 3485-3496.
23. Pear WS, Miller JP, Xu L, Pui JC, Soffer B, et al. (1998) Efficient and rapid induction of a chronic myelogenous leukemia-like myeloproliferative disease in mice receiving P210 bcr/abl-transduced bone marrow. Blood 92: 3780-3792.
24. Castellano E, De Las Rivas J, Guerrero C, Santos E, (2007) Transcriptional networks of knockout cell lines identify functional specificities of H-Ras and N-Ras: significant involvement of N-Ras in biotic and defense responses. Oncogene 26: 917-933.
25. Daniels MA, Teixeiro E, Gill J, Hausmann B, Roubaty D, et al. (2006) Thymic selection threshold defined by compartmentalization of Ras/MAPK signaling. Nature 444: 724-729.
26. Weigers GJ, Kaufmann M, Tischner D, Villunger A, (2011) Shaping the T-cell repertoire: a matter of life and death. Immunol & Cell Biol 89: 33-39.
27. Ohgaki R, Matsushita M, Kanazawa H, Ogihara S, Hoekstra D, et al. (2010) The Na+/H+ exchanger NHE6 in the endosomal recycling system is involved in the development of apical bile canalicular surface domains in HepG2 cells. Mol Biol Cell 21: 1293-1304.
28. Ohgaki R, IJzendoorn SCD, Matsushita M, Hoekstra D, Kanazawa H, (2011) Organellar Na+/H+ exchangers: novel players in organelle pH regulation and their emerging functions. Biochemistry 50: 443-450.
29. Gilfillan GD, Selmer KK, Roxrud I, Smith R, Kyllerman M, et al. (2008) SLC9A6 mutations cause X-linked mental retardation, microcephaly, epilepsy, and ataxia, a phenotype mimicking Angelman syndrome. Am J Hum Genet 82: 1003-1010.
30. Garbern JY, Neumann M, Trojanowski JQ, Lee VM-Y, Feldman G, et al. (2010) A mutation affecting the sodium/proton exchanger, SLC9A6, causes mental retardation with tau deposition. Brain 133: 1391-1402.
31. Li X, Tedder TF, (1999) CHST1 and CHST2 sulfotransferases expressed by human vascular endothelial cells: cDNA cloning, expression, and chromosomal localization. Genomics 55: 345-347.
32. Iida A, Saito S, Sekine A, Mishima C, Kitamura Y, et al. (2002) Catalog of 77 single-nucleotide polymorphisms (SNPs) in the carbohydrate sulfotransferase 1 (CHST1) and carbohydrate sulfotransferase 3 (CHST3) genes. J Hum Genet 47: 14-19.
33. Jutila MA, Kurk S, (1996) Analysis of bovine γδ T cell interactions with E-, P-, and L-selectin: characterization of lymphocyte on lymphocyte rolling and the effects of O-glycoprotease. J Immunol 156: 289-296.
34. LiLi T, Murphy PG, Li X, Tedder TF, (1999) L-selectin ligands expressed by human leukocytes are HECA-452 antibody-defined carbohydrate epitopes preferentially displayed by P-selectin glycoprotein ligand-1. J Immunol 163: 5070-5078.
35. Li X, Murphy PG, Kadono T, Steeber DA, Tedder TF, (2001) CHST1 and CHST2 sulfotransferase expression by vascular endothelial cells regulate shear-resistant leukocyte rolling via L-selectin. J Leukoc Biol 69: 565-574.
36. Munakata K, Iwamoto K, Bundo M, Kato T, (2005) Mitochondrial DNA 3243A>G mutation and increased expression of LARS2 gene in brains of patients with bipolar disorder and schizophrenia. Biol Psychiatry 52: 525-532.
37. Zhou W, Feng X, Li H, Wang L, Zhu B, et al. (2009) Inactivation of LARS2, located at the commonly deleted region 3p21.3, by both epigenetic and genetic mechanisms in nasopharyngeal carcinoma. Acta Biochim Biophys Sin 41: 54-62.
38. Wang X, (2001) The expanding role of mitochondria in apoptosis. Genes Devel 15: 2922-2933.
39. Chandra D, Liu J-W, Tang DG, (2002) Early mitochondrial activation and cytochrome c upregulation during apoptosis. J Biol Chem 277: 50842-50854.
40. Benedict CL, Gilfillan S, Thai T-H, Kearney JF, (2000) Terminal deoxynucleotidyl transferase and repetoire development. Immunol Rev 175: 150-157.
41. Zou Y-R, Sunshine M-J, Taniuchi I, Hatam F, Kileen N, et al. (2001) Epigenetic silencing of CD4 in T cells committed to the cytotoxic lineage. Nat Genetics 29: 332-336.
42. Su R-C, Brown KE, Saaber S, Fisher AG, Merkenschlager M, et al. (2004) Dynamic assembly of silent chromatin during thymocyte maturation. Nat Genetics 36: 502-506.
43. Su R-C, Sridharan R, Smale ST, (2005) Assembly of silent chromatin during thymocyte development. Sem Immunol 17: 129-140.